Understanding the true origins and composition of tirzepatide helps patients make informed decisions about this dual GIP/GLP-1 receptor agonist therapy
ADA Innovation Hub Title: Mechanistic Insights into Weight Loss and Metabolic Regulation of Obese Mice Treated with Nimacimab, a Peripherally-restricted CB1 Inhibitor In this ADA symposium, Chris Twitty, PhD, CSO, reviewed the distinguishing characteristics of nimacimab, reiterated meaningful weight loss data from a pre-clinical diet-induced obesity model that underscores nimacimab's potential as a standalone obesity treatment and as a combination therapy, and introduced new biomarker data showing important reductions in obesity-induced inflammation and liver steatosis
A smaller syringe (0.3 mL or 0.5 mL) may now be more appropriate for improved precision
The Precision Peptide Genetic Test ($298) identifies genetic variants affecting glucose reabsorption, immune function, and renal pathwaysall of which influence UTI susceptibility during semaglutide use
Important: Ask your healthcare provider about your dose of SYMLIN and how to inject SYMLIN the right way before you inject it for the first time